Fibrosis Facts

100 Facts About Liver Fibrosis

Definition & Basics

  1. Liver fibrosis is the buildup of scar tissue in the liver from ongoing injury.

  2. It is a repair process that becomes harmful when injury is chronic.

  3. Fibrosis is not a single disease but a shared response across many liver conditions.

  4. The medical root "fibro-" refers to fibrous scar tissue.

  5. Scar tissue is made mostly of collagen.

  6. Fibrosis exists on a spectrum from none to cirrhosis.

  7. Cirrhosis is the most advanced, severe stage of fibrosis.

  8. Fibrosis stage is the strongest predictor of long-term liver outcomes.

  9. Earlier-stage fibrosis can be reversible if the cause is treated.

  10. Fibrosis is distinct from inflammation, which is the injury response that often drives it.

The Cells & Biology

  1. Hepatic stellate cells are the main drivers of fibrosis.

  2. When activated, stellate cells produce excess collagen.

  3. The extracellular matrix is the protein scaffolding that expands during fibrosis.

  4. Normal liver has a delicate matrix; fibrosis distorts it.

  5. Chronic inflammation typically precedes and drives scarring.

  6. Immune signaling molecules (cytokines) help activate fibrosis.

  7. Oxidative stress contributes to the injury that leads to scarring.

  8. The liver has a strong regenerative capacity, but chronic injury overwhelms it.

  9. Fibrosis reflects an imbalance between scar formation and scar breakdown.

  10. Specialized enzymes can break down scar tissue when injury stops.

Causes

  1. Metabolic fatty liver disease (NASH/MASH) is a leading cause of fibrosis.

  2. Chronic hepatitis C is a major global cause.

  3. Chronic hepatitis B is another leading worldwide cause.

  4. Chronic heavy alcohol use is a major cause.

  5. Autoimmune hepatitis can cause progressive fibrosis.

  6. Primary sclerosing cholangitis (PSC) causes biliary fibrosis.

  7. Primary biliary cholangitis (PBC) causes biliary fibrosis.

  8. Hemochromatosis (iron overload) can lead to fibrosis.

  9. Wilson's disease (copper overload) can cause fibrosis.

  10. Certain medications and toxins can injure the liver and cause scarring.

  11. Multiple causes can combine and accelerate fibrosis.

  12. Bile duct obstruction can lead to fibrosis over time.

Risk Factors & Progression Drivers

  1. Type 2 diabetes is linked to faster fibrosis progression.

  2. Obesity accelerates fibrosis, especially in metabolic liver disease.

  3. Insulin resistance contributes to progression.

  4. Genetic variants like PNPLA3 influence progression risk.

  5. Older age is associated with faster progression in many conditions.

  6. Male sex is associated with higher progression risk in some diseases.

  7. Ongoing alcohol use accelerates fibrosis across liver diseases.

  8. Coexisting liver conditions raise progression risk.

  9. Poorly controlled metabolic health speeds progression.

  10. High viral load in untreated hepatitis can drive faster scarring.

How It Progresses

  1. Fibrosis usually develops slowly, over years.

  2. Progression rates vary widely between individuals.

  3. "Bridging fibrosis" describes scar tissue connecting regions of the liver.

  4. Advancing fibrosis distorts the liver's internal architecture.

  5. Scarring impedes normal blood flow through the liver.

  6. Portal hypertension (raised pressure in liver blood vessels) results from advanced scarring.

  7. Fibrosis can progress silently, without symptoms.

  8. Not everyone with fibrosis progresses to cirrhosis.

Staging

  1. Fibrosis is described in stages, commonly F0 to F4.

  2. The METAVIR system is a widely used staging scale.

  3. F0 means no fibrosis.

  4. F1 means mild fibrosis without bridging.

  5. F2 means moderate fibrosis with early bridging.

  6. F3 means advanced fibrosis with bridging, but not cirrhosis.

  7. F4 means cirrhosis.

  8. "Significant fibrosis" generally means F2 or higher.

  9. "Advanced fibrosis" generally means F3–F4.

  10. The Ishak system is another staging scale, often used in research.

  11. Staging reflects scarring; grading reflects inflammation/activity.

Symptoms

  1. Early fibrosis usually causes no symptoms.

  2. Fibrosis is often called "silent" for this reason.

  3. Symptoms typically appear only at advanced stages.

  4. Fatigue can occur as fibrosis advances.

  5. Advanced disease can cause jaundice, swelling, and confusion.

  6. Easy bruising can signal advanced liver dysfunction.

  7. Many people have significant fibrosis yet feel completely well.

Diagnosis & Testing

  1. Fibrosis is assessed with blood tests, imaging, and sometimes biopsy.

  2. FIB-4 is a simple blood-based fibrosis risk score.

  3. The APRI score uses AST and platelets to estimate fibrosis.

  4. The ELF test is a blood panel measuring scarring markers.

  5. FibroScan (transient elastography) measures liver stiffness.

  6. Stiffer livers generally indicate more fibrosis.

  7. MR elastography is a highly accurate imaging method for fibrosis.

  8. Ultrasound can suggest chronic liver changes but doesn't stage fibrosis precisely.

  9. Liver biopsy remains the gold standard for staging.

  10. A biopsy reveals the exact stage and pattern of scarring.

  11. Noninvasive tests increasingly reduce the need for biopsy.

  12. Fibrosis test results can be affected by other factors, so context matters.

Complications

  1. Advanced fibrosis can progress to cirrhosis.

  2. Cirrhosis is largely irreversible, though progression can be slowed.

  3. Portal hypertension is a key complication of advanced scarring.

  4. Ascites (fluid buildup) can result from advanced fibrosis.

  5. Variceal bleeding is a serious complication of portal hypertension.

  6. Hepatic encephalopathy (confusion) can occur with advanced disease.

  7. Advanced fibrosis and cirrhosis raise liver cancer risk.

  8. The most severe fibrosis can lead to liver failure.

  9. Higher fibrosis stages are associated with higher mortality.

Reversibility & Management

  1. Earlier-stage fibrosis can improve when the underlying cause is treated.

  2. Curing hepatitis C can lead to fibrosis regression.

  3. Stopping alcohol can improve alcohol-related fibrosis, especially early on.

  4. Losing 7–10% of body weight can improve fibrosis in metabolic fatty liver.

  5. Good diabetes and metabolic control support fibrosis improvement.

  6. The Mediterranean diet has strong evidence in metabolic liver disease.

  7. Resmetirom (Rezdiffra) was FDA-approved in 2024 for MASH with fibrosis.

  8. Many additional anti-fibrotic drugs are in clinical trials.

  9. Hepatitis A and B vaccines help protect an already-injured liver.

  10. At the cirrhosis stage, regular liver cancer screening is recommended.

  11. Early detection offers the best chance to reverse or halt fibrosis.